Vedolizumab for Inflammatory Bowel Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study: ICC Registry – Vedolizumab

VBC Biemans, C.J. van der Woude, G Dijkstra, AEE de Jong, B Oldenburg, NK de Boer, M Löwenberg, N Srivastava, AG Bodelier, RL West, JM Jansen, Annemarie de Vries, JJL Haans, D de Jong, MJ Pierik, F Hoentjen

Research output: Contribution to journalArticleAcademic

24 Citations (Scopus)
20 Downloads (Pure)
Original languageEnglish
Pages (from-to)1189-1199
Number of pages11
JournalClinical Pharmacology and Therapeutics
Issue number5
Publication statusPublished - 2020

Research programs

  • EMC MM-04-20-01

Cite this